Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy
IntroductionTherapeutic treatment for advanced-stage (T2–T4) gastroesophageal junction (GEJ) and gastric cancer involves neoadjuvant chemotherapy with subsequent surgical intervention.MethodNeoadjuvant oncological treatment for GEJ and gastric cancer previously consisted of the intravenous administr...
Main Authors: | Attila Paszt, Zsolt Simonka, Krisztina Budai, Zoltan Horvath, Marton Erdos, Marton Vas, Aurel Ottlakan, Tibor Nyari, Zoltan Szepes, Gabriella Uhercsak, Aniko Maraz, Laszlo Torday, Laszlo Tiszlavicz, Judit Olah, Gyorgy Lazar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2023.1148984/full |
Similar Items
-
Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
by: Attila Paszt, et al.
Published: (2022-12-01) -
Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients
by: Katarzyna Marcisz-Grzanka, et al.
Published: (2024-02-01) -
An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers
by: Prabhat Bhargava, et al.
Published: (2022-04-01) -
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
by: Sylvie Lorenzen, et al.
Published: (2020-09-01) -
Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma
by: Björn-Ole Stüben, et al.
Published: (2022-02-01)